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Abstract Laser capture microdissection (LCM) enables
collection of cell populations highly enriched for specific cell
types that have the potential of yielding critical information
about physiological and pathophysiological processes. One
use ofcells collectedbyLCMisforgeneexpressionprofiling.
Samples intended for transcript analyses should be of the
highest quality possible. RNA degradation is an ever-present
concern in molecular biological assays, and LCM is no
exception. This paper identifies issues related to preparation,
collection, and processing in a lipid-rich tissue, rodent
mammary gland, in which the epithelial to stromal cell ratio
is low and the stromal component is primarily adipocytes, a
situationthatpresentsnumeroustechnicalchallengesforhigh-
qualityRNAisolation.Ourgoalwastoimprovetheprocedure
so that a greater probe set present call rate would be obtained
when isolated RNA was evaluated using Affymetrix micro-
arrays. The results showed that the quality of RNA isolated
from epithelial cells of both mammary gland and mammary
adenocarcinomaswashighwitha probesetpresentcallrateof
65% and a high signal-to-noise ratio.
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Abbreviations
AOI Area of interest
DOA Days of age
LCM Laser capture microdissection
LN Lymph node
MA Mammary adenocarcinoma
MG Mammary gland
NF Nuclease free
OCT Optimal cutting temperature
RIN RNA integrity number
ROI Region of interest
WB Wash buffer
1 Introduction
Rodent models of breast cancer continue to play a crucial
role in discovering new approaches to treatment and
prevention of the disease. Microarrays offer investigators
the ability to screen thousands of genes per sample [1–5].
However, heterogeneous tissue may confound molecular
analysis because it is currently impossible to discern which
cells contribute which cellular constituents to a given tissue
lysate. Laser capture microdissection (LCM) allows specific
cell populations to be harvested, thus reducing the amount
of biological noise while increasing the sensitivity of
microarrays enabling detection of subtle differences in gene
expression profiles among control and treatment groups [6].
Specific cell populations can be harvested from frozen or
paraffin tissue sections using LCM [7–10]. However, RNA
obtainedfromformalin-fixedparaffin-embeddedtissuecanbe
significantly degraded due to fragmentation and modification
of the template through the addition of mono-methylol
groups to the bases, thus interfering with RNA extraction
and subsequent amplification [11–14]. Alternative methods
of fixation and processing have been proposed for preserva-
tion of RNA in paraffin-embedded samples [15–17].
Nevertheless, they have not gained wide acceptance, and
frozen tissue remains the gold standard for obtaining high-
quality RNA.
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tissues presents many challenges, and rat mammary gland
(MG) presents specific obstacles due to the high adipose
content and relative low abundanceoffibrous connective tissue
as compared to human breast (Fig. 1). Capturing the limited
number of epithelial cells available in each MG sample is a
race against time in order to preserve RNA integrity. While
there are a growing number of articles on the subject of LCM,
few have reported optimized conditions and detailed hands-on
procedures to obtain high-quality RNA suitable for micro-
array analysis from rodent MG that yields a high percent call
rate when the RNA is arrayed on commercially available
microarrays suchasthe Affymetrixplatform[13, 18–23]. Our
laboratory spent over a year of developing, refining, and
optimizing techniques necessary to overcome the inherent
obstacles in rat MG prior to publication [24]. Colleagues
have inquired regarding specific details of our approach to
MG whole mount preparation, cryosectioning, and process-
ing for LCM and RNA isolation. Therefore, it is our intent to
describe in detail the techniques that resulted from addressing
the following questions: (1) what is the best approach to
obtain frozen sections of mammary adenocarcinoma (MA)
and normal rat MG suitable for LCM; (2) can sections for
LCM be stained without affecting RNA quality; (3) what is
the ideal dehydration procedure for the preservation of RNA
integrity; (4) how many LCM caps and laser fires per cap are
necessary to produce a sufficient amount RNA for down-
stream gene array analyses; and (5) what is the maximum
amount of time permitted for LCM per cap in order to
maintain high-quality RNAyield?
2 Materials and Methods
Female Sprague–Dawley rats were obtained from Taconic
farms (Germantown, NY) at 20 days of age (DOA). At 21
DOA, rats were given an i.p. injection of 50 mg 1-methyl-
1-nitrosourea per kilogram body weight, Ash Stevens,
Detroit, MI [25]. Animals were euthanized based on
palpated tumor diameter ≤0.5 cm. A tumor was excised
when its diameter reached ∼0.5 cm or its volume reached
∼62.5 mm
3 and was immediately snap-frozen in liquid
nitrogen. The contralateral abdominal inguinal MG chain
was excised from the same animal, spread as a whole
mount on transparency film (3M, St. Paul, MN., cat. no.
PP2500), and lymph node (LN) chain marked on the
underside of the film before snap freezing in liquid
nitrogen. All samples were stored at −80°C. The work
followed ethical guidelines approved by the Colorado State
University Animal Care and Use Committee. One small
frozen MA of relatively equal size was chosen from each
animal for LCM in recognition that smaller tumors would
have minimal necrosis, which adversely effects RNA
quality. A representative area of frozen MG near the LN
region in gland 4 was selected for LCM to serve as the
source of reference (control) mammary epithelial cells.
Nuclease-free (NF) technique was used during all
subsequent stages of sample handling. A heat extractor
was used to both flatten and expedite freezing of the
optimal cutting temperature (OCT) embedding media
(Sakura Finetek, Torrance, CA., cat. no. 4583). MA and
MG cryosections were cut at 7 and 10 µm, respectively
(Leica Microsystems, Bannockburn, IL., cat. no. CM1850)
and placed on plain glass slides (Surgipath Medical Ind.,
Inc., Richmond, IL., cat. no. 00330). Slides were placed on
aPeltiercooledcryobar(−60°C)immediatelyaftersectioning.
Once frozen, slides were moved to pre-cooled plastic slide
box (BD Biosciences, San Jose, CA., cat. no. 423843) located
inside the cryo-chamber while additional sections were cut
(Fig. 2). A total of 25 slides were cut for each sample and
total sectioning time was ≤20 min. Slides were stored at
−80° until LCM could be performed.
Plastic slide staining jars (Evergreen Scientific, Los
Angeles, CA., cat. no. 240-5440-G8K) were cleaned with
RNaseZap® (Applied Biosystems/Ambion, Austin, TX cat.
no. 9780), rinsed in DEPC-treated water, and allowed to air
dry completely under a fume hood. Staining jars were
Fig. 1 Human breast vs. rat MG. a Normal human breast ductal
epithelium surrounded by thick fibrous connective tissue (arrows),
H&E, ×400, bar=10 µm. b Normal rat MG depicting ductal
epithelium with a thin layer of connective tissue (arrows) surrounded
by numerous adipocytes, H&E, ×400, bar=10 µm
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Chester, PA., cat. no. 66022-503) to prevent spillage. Slides
were removed from the −80°C freezer and the slide box
transported under dry ice to a chemical fume hood near the
AutoPix® LCM instrument (Molecular Devices, Sunnyvale,
CA). Slides were removed from under dry ice one at a time,
not allowed to thaw, and immediately dehydrated using NF
HistoGene® refill kit (Molecular Devices, cat. no.
KIT0419) reagents according to the following modified
protocol: 75% EtOH, H20, 75% EtOH, 95% EtOH, and
100% EtOH all for 30 s each followed by xylene for 1 min
and air drying for 1 min [24]. To maximally remove OCT,
one brief H20 rinse was adopted to shorten incubation time
in 75% EtOH because the timing is critical for obtaining
high quality of RNA. Slides were agitated vertically several
times in each reagent to ensure reagent transfer and
adequate dehydration. Each slide was immersed diagonally
in the slide jar as opposed to using the plastic grooves
provided, which allowed greater freedom of movement
during agitation in each reagent. No more than four slides
were passed through each set of reagents in order to
minimize carryover. Each slide was quickly inspected to
make sure that no residual xylene was present on the tissue
or slide, which could damage the polymer on the surface of
the LCM cap. Grossly visible folds or wrinkles present at
the periphery of the tissue were removed using a sterile NF
scalpel blade. In addition, a PrepStrip™ (Molecular
Devices, cat. no. LCM207) static strip was applied to each
tissue section to flatten and remove any loosely bound
material that might interfere with proper seating of the
LCM cap. Slides were placed on the AutoPix® instrument
one at a time and a CapSure® macro cap (Molecular
Devices, cat. no. LCM0211) was placed directly on top of
the dehydrated tissue section and off center such that
slightly more than half of the cap surface covered the tissue
and the remainder covered a blank portion of the glass
slide. Laser parameters were adjusted to ensure adequate
wetting and subsequent capture. A small region of interest
(ROI) comprising ≤30 microscopic field tiles was selected
at ×10 and acquired as a static image. An Intuos digital
tablet (Wacom, Vancouver, WA) was used to draw multiple
areas of interest (AOI) on the static image intended for
LCM (Fig. 3a). The IR laser wasfiredcapturingonlythecells
lying within the marked AOIs. The cap was placed on a blank
portionoftheglassslideandtheentirecapareaquicklyimaged
at ×4 magnification to verify cell collection (Fig. 3b). Stromal
debris was more prominent in captures from MG than in MA
(Fig. 3c). Debris was removed by lightly stamping the cap on
the tacky portion of a clean adhesive note (3M, cat. no.
MMM654YW) three times, which removed debris but left
captured epithelium intact (Fig. 3d)[ 10]. The cap was placed
on a 0.5-mL microfuge tube (Applied Biosystems, Foster
City, CA., cat. no. N8010611) containing 30 µL of PicoPure®
RNA extraction buffer (Molecular Devices, cat. no.
KIT0204), inverted, and gently tapped on the bench top
several times to ensure adequate coverage across the surface
of the polymer. A total of four caps from each MA and eight
caps from each MG were collected.
2.1 RNA Extraction
A dry bath and heating block were pre-warmed to 42°C.
The heating block was removed and inverted tubes were
quickly placed at the bottom of the dry bath. The heating
Fig. 2 Laser capture microdissection. Cryosectioning chamber
depicting MG whole mount bisected through the LN chain (red
dashed line). Bisected MG halves were mounted on separate object
holders and rotated at a slight angle with respect to the blade. The LN
chain served as an anchoring point, making it easier to section MG
with high adipose content
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adequate heat retention, and incubated at 42°C for 30 min
(Fig. 4). Tubes were centrifuged for 2 min at 800×g to
collect cell extract and stored at −80°C until the remaining
portion of the RNA extraction procedure could be completed.
ThePicoPure®kit(MolecularDevices,cat.no.KIT0204)was
used to extract RNA. Briefly, RNA purification columns were
prepared by adding 250 µL of conditioning buffer onto the
purification column filter membrane and incubating for 5 min
at room temperature. The column collection tube was
centrifuged at 16,000×g for 1 min. The cell extract was
treated with 30 μL of 70% EtOH and mixed well. The cell
extract EtOH mixture was pipetted into the pre-conditioned
purification column and centrifuged for 2 min at 100×g to
bind RNA to the column, immediately followed by a
centrifugation at 16,000×g for 30 s to remove flow-through.
Cell extracts isolated from multiple LCM caps of each
sample, four MA and eight MG caps, respectively, were
processed through the same column to increase RNA yield.
Wash buffer 1 (WB1, 100 μL) was added to the purification
column and centrifuged for 1 min at 8,000×g. DNase
working solution was diluted by adding 5 μLD N a s eIs t o c k
solution DNase, RNase-Free DNase Set (Qiagen, cat. no.
79254) to 35 μL buffer RDD (provided with NF Set) and
mixed by gently inverting. Forty microliters of the DNase
working solution was added directly into the purification
column membrane and incubated at room temperature for
15 min. The DNase was washed by adding 40 μLP i c o P u r e ®
RNA Kit WB1 to the purification column membrane and
centrifuged at 8,000×g for 15 s, followed by a second buffer
wash, 100 μL wash buffer 2 (WB2), and centrifuged for
1 min at 8,000×g. The column was washed again by adding
100 μL WB2 into the purification column and centrifuged
for 2 min at 16,000×g. The column was inspected for any
residual WB and if found was re-centrifuged at 16,000×g for
1 min. The column was transferred to a new 0.5-mL
microcentrifuge tube provided in the kit. RNA was eluted
by adding 11 μL of elution buffer directly onto the
membrane of the purification column and incubated for
1 min at room temperature followed by centrifugation of the
Fig. 3 a Unstained MA section showing AOIs marked in red. b Image of LCM cap showing captured epithelial AOIs. c LCM of normal MG
depicting stromal debris attached to the macro cap. d Cap area from panel C after removal of stromal debris via adhesive note
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isolated RNA was stored at −80°C.
2.2 Total RNA Quantity and Integrity
The concentration of each total RNA sample was determined
using a NanoDrop® ND-3300 Fluorospectrometer (NanoDrop,
Wilmington, DE). The assay measured fluorescence of Ribo-
Green dye at 525 nm following excitation at 470 nm. RNA
concentration was calculated based on a standard curve. The
integrity of total RNA samples was examined by Experion
(Bio-Rad, Hercules, CA, cat. no. 700-7001) using the Experion
RNA HighSens analysis kit (cat. no. 700-7105).
2.3 RNA Amplification and Labeling for Microarray
TheOvation™BiotinRNAamplificationandlabelingsystem
was used for amplification and labeling (NuGEN Technolo-
gies, Inc., San Carlos, CA., cat. no. 2300). The Ovation™
Biotin System is powered by Ribo-SPIATechnology, a rapid,
simple, and sensitive RNA amplification process. A detailed
protocol is described in the user’s guide kit and was used
without modification as reported previously [24].
2.4 Hybridization, Washing, and Staining of the Affymetrix
GeneChip® Rat Genome 230 2.0 Arrays
Hybridization was performed by incubating 200 μL of the
above hybridization cocktail to the Affymetrix GeneChip®
arrays (Affymetrix, Inc., Santa Clara, CA). Hybridization
occurred at 45°C for 16 h using a GeneChip® Hybridiza-
tion Oven 640 (Affymetrix). After hybridization, the
hybridization solutions were removed and the arrays
washed and stained with streptavidin-phycoerythrin using
a GeneChip® Fluidics Station 450 (Affymetrix). Arrays were
read at a resolution of 2.5 to 3 Am using the GeneChip®
Scanner 3000 (Affymetrix).
2.5 Statistical Analyses
Raw expression values from 42 chips of the Affymetrix Rat
Genome 230 2.0 were generated using GeneChip® Operating
Software (Affymetrix). All analyses were performed using
Systat statistical analysis software, version 12 (Systat Software,
Inc., San Jose, CA)
3 Protocol
3.1 Necropsy
1. Harvest all tissues as quickly as possible, i.e., <4 min
from time of killing.
2. Excise the abdominal–inguinal MG chain from one
side of the animal and spread onto a pre-cut piece of
transparency film, mark the lymph node chain on the
bottom of the film using a permanent marker, place in a
4×6-in. heat seal bag (do not seal), and snap freeze in
liquid nitrogen without embedding in OCT.
3. Excisetumors,placeincryovials,andsnapfreezeinliquid
nitrogen.
4. Store tissues at −80°C until ready to cut frozen sections.
3.2 Cryosectioning
1. Clean the cryostat chamber, including the knife blade
holder with 200 proof ethanol.
2. Remove a disposable microtome blade previously
stored in 200 proof ethanol, allow to air dry, and
insert into the cryostat knife blade holder.
3. Set cryostat to optimized temperature for tissue type and
allow time to equilibrate, e.g., −24°C for mammary
tumor or −30°C for MG.
Fig. 4 Proper inverted orientation of microfuge tubes and heating
block. Microfuge tubes were kept inverted during initial RNA
extraction, ensuring adequate coverage of extraction buffer across
the surface of the LCM cap
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port under dry ice, and place the sample in the cryostat.
5. MG: Remove film-mounted gland from bag, bisect the
gland longitudinally through the marked lymph node
chain using a clean scalpel or razor blade, then cut
above the superior node and below the inferior node
to obtain two halves of mammary tissue.
6. Using a room temperature object holder, dispense
enough OCT on the holder to adequately cover the
surface and place it on the cryobar to cool.
7. Once the OCT begins to turn opaque, place the sample
on top of the OCT, dispense additional OCT to cover
the sample, and place a heat extractor on top to flatten
and freeze the OCT quickly.
8. Place the object holder in the chuck of the cryotome
and rotate. MG tissue should be rotated with the
edge of the lymph node chain angled to the knife
blade.
9. Adjust cuttingdepthto 7 µm fortumor or10 µm forMG.
10. Cut sections and place on clean, room temp, plain
glass slides (orient sections in the middle toward the
lower half of the slide).
11. Immediately place the slide on the Peltier cooled
portion of the cryobar to freeze as quickly as possible.
12. Once frozen, place the slide in a pre-cooled, clean, small
plastic slide box inside the cryo chamber. One box per
sample.
13. Cut additional sections for use as replicates to minimize
freeze/thaw problems, but limit total sectioning time
to <20 min.
14. Return the sample and slide box of cut sections to
−80°C until ready for dehydration and LCM.
3.3 Dehydration
1. Fill pre-cleaned (nuclease-free) plastic staining jars
with Histogene® reagents and order as follows: 75%
ethanol (EtOH), H20, 75% EtOH, 95% EtOH, 100%
EtOH, xylene.
2. Remove one sample at a time from −80°C and transport
under dry ice to the chemical fume hood.
3. Remove one slide from the slide box; do not thaw and
immerse immediately in 75% EtOH for 30 s. Transfer
the slide from one reagent to the next in the order listed
above and incubate for 30 s in each reagent with the
exception of xylene (1 min). A pair of forceps should
be used to agitate the slide vertically in each reagent
solution for the duration of each incubation period in
order to ensure adequate reagent transfer. Regent
should be drained from the slide prior to immersion in
subsequent reagents to minimize cross-contamination.
No more than four slides should be used in one set of
reagents. The slide should be air-dried under the fume
hood. Rapid reciprocal movement of the slide under the
hood will help facilitate the air drying process.
4. Inspect the slide for any folds, wrinkles, or debris at the
edgesofthetissuesectionandremovewithacleanscalpel
blade.
5. Place a PrepStrip™ on top of the dried tissue section,
rub index finger or thumb over the length of the strip
three to four times, and peel the strip off of the section
to remove any debris that might interfere with seating
of the laser capture microdissection (LCM) cap.
6. Proceed immediately with LCM.
3.4 Laser capture microdissection
1. Load the dry slide in the LCM instrument, focus, and
acquire a road map image of the tissue section.
2. Move the red box on the road map image to the desired
location, right click, and choose “place cap at region
center.” The cap should be position such that only one
half to three fourths of the cap surface covers the tissue
section with the remainder covering a blank portion of
the glass slide.
3. Using the ×10 objective, bring the tissue section into
focus then move the active window to a blank portion
of the cap.
4. Locate and focus the laser then test fire to verify
adequate wetting (black ring with a clear center).
5. Default laser settings for pulse (1,500 µs), hits (1)
and delay (0) should be adequate for 7-µm tumor
sections, but the power level may need to be
increased from 60 to 90 mW. Thicker MG sections
(10 µm) may require increasing the number of hits
from 2 to 20, and the delay should be increased from
0 to 10 µs.
6. Test fire the laser and set the spot size.
7. Draw a ROI on road map image and acquire the
region as static image (no more than 30 image tiles).
8. Use adigitaltabletinconjunctionwiththefree-handline
and polygon tools to quickly draw or mark multiple
areas on the static image intended for capture. When
finished, right click and choose capture. Repeat the ROI
selection and marking process on different areas within
the cap as time permits.
9. Unload the cap and stamp three times on tacky portion
of a clean self-adhesive note to remove debris.
10. Place the cap on a blank portion of the glass slide and
reacquire the road map image.
11. Using the ×4 objective, draw a ROI around the cap
and acquire as a static image. Inspect the image to
verify successful capture of epithelial cells.
12. Open and pull the lid completely off of the microfuge
tube filled with 30 µL of RNA extraction buffer
(PicoPure® RNA isolation kit).
36 McGinley et al.13. Remove the cap from the slide and seat the cap on the
microfuge tube, being careful not to crack the tube.
14. Invert the tube and tap on the bench top several times
to ensure the buffer covers the surface of the cap.
15. Total time from start of dehydration procedure to
extraction buffer should be ≤30 min.
3.5 RNA Extraction
1. Place inverted tubes in a pre-warmed heating block
and incubate at 42°C for 30 min.
2. Remove the tubes from the heating block and
centrifuge at 800×g for 2 min.
3. Store tubes at −80°C or proceed with remainder of
extraction procedure.
4. Pre-condition the RNA purification column using
250 µL of conditioning buffer and incubate for 5 min
at room temp.
5. Centrifuge the column at 16,000×g for 1 min.
6. Pipette 30 μL of 70% EtOH into the cell extract from
RNA extraction and mix by pipetting up and down;
do not centrifuge.
7. Pipette the cell extract and EtOH mixture into the pre-
conditioned purification column.
8. Centrifuge for 2 min at 100×g followed by centri-
fugation at 16,000×g for 30 s to bind RNA to the
column.
9. Pipette 100 μL WB1 into the purification column and
centrifuge for 1 min at 8,000×g.
10. DNase treatment (use RNase-Free DNase Set (Qiagen,
catalog no. 79254).
11. Pipette 5 μL DNase I stock solution into 35 µL Buffer
RDD (provided with RNase-Free DNase Set) and mix
by gently inverting.
12. Pipette the 40 μL DNase incubation mix directly into
the purification column membrane and incubate at
room temperature for 15 min.
13. Pipette 40 μL PicoPure® RNA Kit WB1into the
purification column membrane and centrifuge at
8,000×g for 15 s.
14. Pipette 100 μL (WB2) into the purification column
and centrifuge for 1 min at 8,000×g.
15. Pipette another 100 μL WB2 into the purification
column and centrifuge for 2 min at 16,000×g.
16. Check the purification column for any residual WB. If
WB remains, re-centrifuge at 16,000×g for 1 min.
17. Transfer the column to a new 0.5 mL microcentrifuge
tube provided in the kit.
18. Pipette 11 μL of elution buffer (EB) directly onto the
membrane of the column and incubate for 1 min at
room temperature.
19. Centrifuge the column for 1 min at 1,000×g to
distribute EB in the column.
20. Centrifuge for 1 min at 16,000×g to elute RNA. The
isolated RNA is now ready for use in downstream
applications. The entire sample may be used immedi-
ately or stored at −80°C until ready to use.
4 Results and Discussion
4.1 Cryosectioning
The high adipose content and low abundance of epithelial
cells and connective tissue present in normal MG made the
process of obtaining thin, flat, intact cryosections suitable
for LCM a difficult challenge. While MA sections cut very
nicely at 7 µm, MG sections had to be cut at 10 µm due to
the high adipose content. MG cryosections cut at <10 µm
produced fragmented sections or no sections at all, while
sections >10 µm were too thick for LCM. Other instru-
ments, which offer a UV cutting laser including the Veritas
and Arcturus
XT systems, are able to microdissect tissue
>10 µm. However, The Pixcell and Autopix® instruments
do not have a UV laser to physically cut out AOIs and rely
solely upon the adhesive properties of the polymer to
overcome the shear force necessary to separate the AOIs
from the surrounding tissue and glass slide. The thicker the
tissue section, the greater the shear force required. It has
been reported that large microdissected areas captured via
IR or UV show similar 18/28-s peak profiles, while the
profiles of small areas, e.g. single cells microdissected
using a UV cutting laser, show considerable RNA degra-
dation [26]. Normal ductal mammary epithelium is only
one to two cell layers in thickness and would be subject to
much higher levels of RNA damage than large areas of MA
captured by UV. Conversely, the IR laser only reacts with
polymer coating on the cap and does not harm the
underlying tissue irrespective of the area captured.
MG sections required colder cutting temperature than
MA sections, −30°C and −24°C, respectively. In many
cases, the normal MG tissue disintegrated upon contact
with the microtome knife blade. However, we found that
bisecting the MG through the long axis of the LN chain and
embedding the tissue with the LN chain angled to the edge
of the knife blade created an anchoring point, which aided
in cryosectioning (Fig. 2). An early attempt was made to
preserve RNA in tissue harvested at necropsy by immersing
the tissue in RNAlater® (Applied Biosytems/Ambion, cat.
no. AM7024). However, the chemical components of this
product greatly interfered with OCT embedding and
subsequent cryosectioning. The best results were obtained
when the tissue was snap-frozen in liquid nitrogen
immediately after excision at necropsy, stored at −80°C,
and, after being embedded in OCT, cryosectioned within
20 min then quickly stored at −80°C.
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The Histogene® kit utilizes aqueous toluidine blue as the
staining component, which requires an additional water
rinse to remove excess stain prior to dehydration. Initial
testing using stained sections revealed significant RNA
degradation (Fig. 5a). Since nucleases are active in aqueous
solutions and it is critical that the time spent in such
solutions be kept to a minimum in order to avoid RNA
degradation, we modified the recommend protocol to
determine if removal of the staining step would increase
RNA quality. Unstained sections yielded higher quality
RNA in the form of higher rRNA 28/18 s ratios (Fig. 5b).
The total time spent in aqueous solution using the standard
Histogene® method is 80–90 s compared to our modified
unstained method of 30 s. A single water rinse was required
in the unstained method to completely remove the OCT
embedding medium after fixation in 75% EtOH. In
addition, the amount of time in xylene and air drying
were reduced from 5 to 1 min each. Given the shortened
incubation times along with the small volume of
reagents, slide forceps were used to provide continued
vertical agitation of the slides in each vial in order to
facilitate reagent transfer during the dehydration process.
Slides were passed through reagents one at a time, and
no more than four slides were ever passed through the
same set of reagents in order to avoid excessive reagent
carryover.
In theory, slides could be dehydrated and stored at −80°C
with desiccant, possibly extending the storage life of cut
sections. However, sections would still need to be dehydrated
again prior to LCM in order to remove any condensation that
may form on the slide as a result of contact with ambient air.
Humidity conditions existing in laboratory environments can
be variable depending upon geographic location. Successful
LCM requires that tissue sections be absolutely dry. If any
moistureispresent inthe tissue,the IRlaser willreactwiththe
water molecules,causing the tissue toheat, thus degrading the
RNA. Moreover, according to Espina et al. [10], complete
dehydration is necessary to minimize the adhesive forces
between the slide and tissue. Dehydrating sections once was
more efficient, saving both time and reagents, and ensured
that the tissue was as dry as possible prior to LCM.
An argument could be made for the removal of all H20
steps in the dehydration procedure: that it serves no useful
purpose except to remove OCT at the periphery of the
tissue and exposure to aqueous environment increases the
risk of RNA degradation, which should be avoided. While
it is true that OCT remains at the periphery of the tissue and
does not penetrate, it can interfere with proper seating of
the cap if it is not removed from the section. The LCM cap
is typically offset on the tissue section, i.e., a portion covers
the tissue of interest while the remainder covers a blank
portion of the glass slide. This is necessary to perform test
fires of the laser in order to ensure adequate wetting, i.e.,
polymer to tissue/slide contact. This procedure must be
Fig. 5 Stained tissue vs. unstained tissue. a Electropherogram of LCM acquired epithelia from Histogene®-stained MA showing significant rRNA
degradation. b Electropherogramof LCM acquired epithelia from unstainedMA showinghigh-qualityrRNA. c Histogene®-stained MA. d Unstained MA
38 McGinley et al.performed on each new cap and every time the cap is
moved to a different location. Laser settings will likely need
to be adjusted in order achieve a similar laser spot size.
Accurate measurement of the spot size is key in providing
the computer the necessary X–Y coordinates in conjunction
with degree of overlap to ensure capture of contiguous
AOI. In addition, caps which cover most or all of the tissue
run a greater risk of being placed on an area that may have
variation in thickness, e.g., folds or wrinkles that will
definitely interfere with proper seating. If the cap is not
seated properly, this causes inconsistencies in the way the
polymer contacts the tissue, which can lead to a phenom-
enon known as polymer depletion described by Espina et
al. [10]. While immersion in graded ethanol, e.g., 75%
EtOH, could remove OCT from the section, it would
require extended incubation time in the reagent. Early
attempts at bypassing the H20 step altogether required
aggressive agitation of the slide in the reagent and resulted
in only partial removal. OCT could be removed by scraping
the peripheral area(s) with a razor blade or scalpel.
However, close visual inspection and physical removal
near the section would be a time-consuming process, not
to mention the possibility of contaminating the surface of
the tissue section with dried flakes of OCT media.
Dehydration and timing are critical. In the interests of
efficiency and reproducibility, it was decided to keep one
brief H20 rinse rather than chance incomplete removal of
the OCT.
An argument could also be made for substituting
aqueous toluidine blue with an alcoholic stain. The intent
was to optimize the original Histogene® procedure [19] for
use with mammary tissue sections by reducing incubation
times or eliminating reagents. Therefore, only the staining
reagent provided in the Histogene® kit was used. Alcoholic-
based versions of toluidine blue or nuclear fast red may fare
better than aqueous stains. However, the authors sought to
challenge the unwritten rule of pathology that tissue must be
stained in order to visualize target cells of interest. Granted
that while the use of unstained sections may not be applicable
toall tissue types, ductaland lobular mammary epitheliumare
easily discernable in unstained sections, and stromal bands of
connective tissue streaming through MA sections provide
adequate contrast in order to differentiate epithelium from
stromal component. Staining and subsequent differentiation
lengthen the time necessary for adequate dehydration of the
tissue, thereby increasing the risk of RNA degradation. The
goal was to keep the modifications simple while maintaining
the highest level of RNA integrity possible. Visualization of
unstained sections (Fig. 5d) was enhanced by lowering the
light intensity on the Autopix® instrument and was fairly
comparable to that obtained in stained tissue (Fig. 5c). Tiled
images of H&E sections were used as guide maps for more
challenging specimens.
4.3 LCM Time Course
To evaluate the impact of LCM duration on RNA quality,
sampleswerecollectedover2h,1h,and30min,respectively.
The 2-h LCM sample showed significant RNA degradation
(Fig. 6a): RNA area = 1,550.1, concentration = 6,949 pg/µL,
rRNA ratio (28/18 s):0.9, and RIN=6.2. The 1-h LCM
sample showed moderate RNA degradation (Fig. 6b): RNA
area = 1,430.8, concentration = 5,373 pg/µL, rRNA ratio
(28/18s):1.3, and RIN = 7.7. The 30-min LCM sample
exhibited minimal RNA degradation (Fig. 6c): RNA area =
1,258.5, concentration = 51,443 pg/µL, rRNA ratio (28/
18 s):1.7, and RIN=8.0. These observations are consistent
with the fact that RNA degradation is a time-dependent
process. The highest quality results were obtained when the
entire LCM process was ≤30 min, i.e., from the point the
slide was removed from dry ice and immersed in 75% EtOH
until captured cells were placed in extraction buffer; thus,
LCM should be performed as quickly as possible to
minimize RNA degradation.
4.4 RNA Quantity
RNA quality and quantity were determined using an
Experion (Bio-Rad) automated electophoresis instrument
and quantity data were validated by Nandrop® ND-3300
fluorospectrophometer (RiboGreen). RNA quantity for both
MA and MG were found to be highly correlated between
the Experion and Nanodrop® (Table 1). Four caps for
tumor (mean cell count per cap = 6,202.2±223.2) and eight
caps for MG sections (mean cell count per cap = 994.2±
42.5) were necessary to provide sufficient amounts of RNA
for downstream gene array analysis using the Ovation™
Biotin RNA amplification and labeling system.
4.5 RNA Quality as Assessed by Microarray Quality
Control Statistics
Average Background and Noise Values Affymetrix QC
statistics specify that average background values should
range from 20 to 100 [27–29]. A total of 42 RNA samples,
21 from MG and 21 from MA, were evaluated. The average
background value was 51.9 with a range of 50.1–53.4
(Table 2). As written in the Affymetrix technical manual,
“the noise measurement is based on the pixel-to-pixel
variation of probe cells on a GeneChip® array, which
comes from electrical noise of the scanner and sample
quality” [30]. The same scanner was used for the analysis
of all chip arrays. The acceptable noise generally should be
<5, and our results were <3 (Table 2).
Percent Present Call The number of probe sets called
“Present” relative to the total number of probe sets on the
Collection of Epithelial Cells from Rodent Mammary Gland 39array is defined as a percentage present (%P), which is
affected by cell/tissue type, RNA quality, environmental or
biological stimuli, and probe array type. The percent
present call should be >35% [31] and typically range
between 35% and 65%. In our experiment from 42 chips,
the mean %P was 65% with a range of 54.9–70.5%
(Table 2). These findings indicate that the overall quality
of RNA for the 42 arrays was high and reproducible.
Poly-A Controls: lys, phe, dap The quality of the labeling
processfortheentiretargetcanbemonitoredbyPoly-ARNA.
As described in the Affymetrix technical manual, “Dap, lys,
phe,a n dtrp are B. subtilis g e n e st h a th a v eb e e nm o d i f i e db y
the addition of poly-A tails, and then cloned into pBluescript
vectors, which contain T3 promoter sequences. Amplifying
these poly-A controls with T3 RNA polymerase will yield
sense RNAs, which can be spiked into a complex RNA
Fig. 6 Electropherogram
comparison of LCM time course
samples from unstained MA.
a LCM duration of 2 h. b LCM
duration of 1 h. c LCM duration
of 30 min. RNA quality
determined by Bio-Rad
Experion
40 McGinley et al.sample, carried through the sample preparation process, and
evaluated like internal control genes” [30]. The dap, lys, phe
spikes should also have ratios <3. Spikes >3 indicate that
there was likely a processing or reagent issue that effected
the IVT reaction, whereas spikes <3 indicate successful
processing. In our experiments, all of the 3′/5′ ratios for the
lys, phe,a n ddap were <3 (Table 2), which suggests that the
sample processing was of high quality.
4.6 Hybridization Controls: bioB, bioC, bioD, and cre
As described in the Affymetrix technical manual, “BioB, bioC
and bioD are genes in the E. coli biotin synthesis pathway. Cre
represents the recombinase gene” [30]. These are pre-labeled
spikes and can be used as an indicator of successful
hybridization, washing, and staining. Anticipated results
should demonstrate an increasing signal trend in the following
order: bioB < bioC < bioD < cre. In our experiments, the
increased trend of bioB, bioC, bioD, and cre in their signal
values was observed (Table 2), which suggest that the
hybridization, washing, and staining were successful and the
efficiency of sample hybridization reached expectation.
5 Conclusions
The intent of this manuscript was to improve upon the
original Histogene® protocol for LCM by shortening
incubation times and eliminating steps in the procedure.
In addition, the high adipose content present in normal
mammary epithelium presents a unique challenge in
obtaining frozen sections suitable for LCM. Attention was
focused on the preparation of material as well as timing at
each stage and did not assume the proficiency level of the
reader as is the case with many publications in the
literature. One particular paper by Upson et al. [22] stands
out and appears to be more focused on the comparison of
amplification protocols and lacks detail in regards to
preparation and timing of both tissue and LCM. In fact,
no mention is made in “Materials and Methods” of any
time-dependent issues related to RNA integrity, thus giving
the reader a false sense of security regarding preparation
and collection. MG and MA were rapidly excised and
immediately snap-frozen in liquid nitrogen. MG was frozen
as a whole mount preparation in order to maintain
anatomical orientation and facilitate cryosectioning. Best
Table 1 RNA yield and LCM cell estimate
Tissue Experion
a (ng/µL) NanoDrop (ng/µL) Total RNA (ng) Laser fires per cap Cell Count per cap
b Cell Count per sample
c
MA (n=27) 7.9±0.8 (2.1, 16.7) 8.6±0.8 (2.3, 17.8) 86 3,277.9±141.0
(778.0; 8,212.0)
6,202.2±223.2
(1,182.6; 12,511.5)
24,808.7±1,270.2
MG (n=27) 4.5±0.4 (1.8, 10.4) 4.9±0.5 (1.8, 14.5) 49 785.6 33.0
(61.0; 2,190.0)
994.2±42.5
(69.5; 2,678.2)
8,192.2±728.3
aValues are means ± SEM (min, max). Good correlation was observed between Experion and NanoDrop results obtained from both MA (r=0.88,
p<0.01) and MG (r=0.83, p<0.01). Cell estimates were calculated based on the formula developed by Espina et al. [10]. Spot sizes ranged from
20 to 40 μm for MA and 10 to 15 μm for MG. A typical cell diameter of 7 µm was used for all rat mammary epithelium, percent overlap was kept
constant at 40%, and 95% efficiency was assumed
bBecause of limitations in the amount of time that could be spent collecting cells on each cap without RNA degradation and the dispensed nature
of cell distribution within MG, there were fewer cells per MG cap and more variability in cell count per cap
cA total of four caps were dissected each MA and eight caps from each MG specimen
Table 2 Quality control of 42 GeneChips®
a
Item MG MA Overall Expected
Background 55±4 49±3 52±2 <100
Noise 2.3±0.2 2.1±0.2 2.2±0.1 <5
Percent present (%) 65±0.6 65±0.8 65±0.5 >35
3′/5′ dap 2.0±0.7 1.7±0.5 1.8±0.4 <3
3′/5′ lys 1.0±0.2 2.3±0.6 1.7±0.3 <3
3′/5′ phe 3.3±0.9 2.1±0.5 2.7±0.5 <3
3′/5′ trp 1.9±0.6 0.7±0.1 1.3±0.3 <3
5′ Signal value bioB 1,562±43 1,585±65 1573±39 Increasing stepwise trend (bioB, bioC, bioD, and cre)
5′ Signal value bioC 4,660±125 4,554±125 4,607±88
5′ Signal value bioD 8,458±229 8,232±242 8,345±165
5′ Signal value cre 25,205±730 24,492±662 24,848±490
aValues are means ± SEM
Collection of Epithelial Cells from Rodent Mammary Gland 41results were obtained when cryosections were prepared in
<20 min. Cryosections, 7 µm and 10 µm, respectively, for
MA and MG, were processed without staining and
epithelial and stromal cells were easily visualized on the
LCM instrument via contrast adjustment of the microscopic
image. Elimination of the staining step and subsequent
water rinse in addition to decreased times for xylene
clearing and air drying provided more time for LCM while
maintaining adequate dehydration necessary for LCM and
preserving RNA integrity. The use of PrepStrips™ to
flatten prior tissue prior to LCM was helpful for both MA
and MG sections. The digital tablet greatly reduced the time
necessary for marking up AOIs for laser capture. Adhesive
notes applied to the cap after LCM greatly aided in the
removal of unwanted debris and did not appear to affect
RNA integrity. Four LCM caps were required for MA
(mean cell count per cap = 6,202.2±223.2) and eight caps
for MG sections (mean cell count per cap = 994.2±42.5) to
provide sufficient amounts of RNA for downstream micro-
array analysis (Table 1). The highest quality RNA was
obtained when the entire LCM process was ≤30 min, i.e.,
from the point the slide was removed from dry ice and
immersed in 75% EtOH until captured cells were placed in
extraction buffer. The evaluation of quality control for all of
the 42 gene chips indicated that the experimental procedures
describedinthe current studyprovidedhigh-qualityRNA that
can be used for gene array to generate high-quality data of
gene expression. This optimized protocol will provide
researchers facing similar challenges in the field of breast
cancer research with a detailed and simplified approach to
LCM that is reproducible and will yield high-quality RNA for
downstream applications including microarray analysis.
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